{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:07:07Z","timestamp":1758629227627,"version":"3.40.5"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1007\/s11033-020-05877-7","type":"journal-article","created":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T10:02:45Z","timestamp":1603706565000},"page":"8397-8405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Interactive effects of interferon-gamma functional single nucleotid polymorphism (+874 T\/A)\u00a0with cardiovascular risk factors in coronary heart disease and early myocardial infarction risk"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-0560","authenticated-orcid":false,"given":"A. Basak","family":"Akadam-Teker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0234-7548","authenticated-orcid":false,"given":"Erhan","family":"Teker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8072-0646","authenticated-orcid":false,"given":"Aynur","family":"Daglar-Aday","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-960X","authenticated-orcid":false,"given":"Kubra Cigdem","family":"Pekkoc-Uyanik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6676-5311","authenticated-orcid":false,"given":"Ezgi Irmak","family":"Aslan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6298-5026","authenticated-orcid":false,"given":"\u00d6zlem","family":"Kucukhuseyin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4383-6890","authenticated-orcid":false,"given":"Gulcin","family":"Ozkara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-6664","authenticated-orcid":false,"given":"Hulya","family":"Y\u0131lmaz-Aydo\u011fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,26]]},"reference":[{"key":"5877_CR1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s00439-009-0654-5","volume":"125","author":"H Roy","year":"2009","unstructured":"Roy H, Bhardwaj S, Yla-Herttuala S (2009) Molecular genetics of atherosclerosis. Human Genet 125:467\u2013491","journal-title":"Human Genet"},{"key":"5877_CR2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.bbacli.2015.02.005","volume":"3","author":"CP Jos\u00e9","year":"2015","unstructured":"Jos\u00e9 CP, Esperan\u00e7a WRR, Miranda JB, Netto FS, Lima LB, LeilaChimelli RS, \u00dcrm\u00e9nyi TP, Cabello PH, EdsonRondinelliFaffe DS (2015) Polymorphisms in IL-10 and INF-\u03b3 genes are associated with early atherosclerosis in coronary but not in carotid arteries: a study of 122 autopsy cases of young adults. BBA Clinical 3:214\u2013220","journal-title":"BBA Clinical"},{"key":"5877_CR3","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1161\/CIRCULATIONAHA.106.676890","volume":"116","author":"I Tabas","year":"2007","unstructured":"Tabas I, Williams KJ, Boren J (2007) Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 116:832\u201344","journal-title":"Circulation"},{"key":"5877_CR4","first-page":"255","volume":"131","author":"PJ L\u0131ttle","year":"2011","unstructured":"L\u0131ttle PJ, Cha\u0131t A, Bob\u0131k A (2011) Cellular and cytokinebased inflammatory processes as novel therapeutic targets for the prevention and treatment of atherosclerosis. PharmacolTher 131:255\u2013268","journal-title":"PharmacolTher"},{"key":"5877_CR5","doi-asserted-by":"crossref","first-page":"e1001146","DOI":"10.1371\/journal.pgen.1001146","volume":"30","author":"S Okser","year":"2010","unstructured":"Okser S, Lehtim\u00e4ki T, Elo LL, Mononen N, Peltonen N, K\u00e4h\u00f6nen M, Juonala M, Fan YM, Hernesniemi JA, Laitinen T, Lyytik\u00e4inen LP, Rontu R, Eklund C, Hutri-K\u00e4h\u00f6nen N, Taittonen L, Hurme M, Viikari JS, Raitakari OT, Aittokallio T (2010) Genetic variants and their interactions in the prediction of increased pre-clinical carotid atherosclerosis: the cardiovascular risk in young Finns study. PLoS Genet 30:e1001146","journal-title":"PLoS Genet"},{"issue":"10","key":"5877_CR6","doi-asserted-by":"crossref","first-page":"e47166","DOI":"10.1371\/journal.pone.0047166","volume":"7","author":"M Garc\u00eda-Berm\u00fadez","year":"2012","unstructured":"Garc\u00eda-Berm\u00fadez M, L\u00f3pez-Mej\u00edas R, Gonz\u00e1lez-Juanatey C, Corrales A, Robledo G, Casta\u00f1eda S, Miranda-Filloy JA, Blanco R, Fern\u00e1ndez-Guti\u00e9rrez B, Balsa A, Gonz\u00e1lez-Alvaro I, G\u00f3mez-Vaquero C, Llorca J, Mart\u00edn J, Gonz\u00e1lez-Gay MA (2012) Analysis of the Interferon gamma (rs2430561, +874T\/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis. Plos One 7(10):e47166","journal-title":"Plos One"},{"key":"5877_CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.atherosclerosis.2009.06.032","volume":"208","author":"M Heiskanen","year":"2010","unstructured":"Heiskanen M, K\u00e4h\u00f6nen M, Hurme M, Lehtim\u00e4ki T, Mononen N, Juonala M et al (2010) Polymorphism in the IL10 promoter region and earlymarkers of atherosclerosis: the cardiovascular risk in young finns study. Atherosclerosis 208:190\u2013196","journal-title":"Atherosclerosis"},{"key":"5877_CR8","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10753-011-9326-4","volume":"35","author":"L De Gennaro","year":"2012","unstructured":"De Gennaro L, Brunetti ND, Montrone D, De Rosa F, Cuculo A, Di Biase M (2012) Subacute inflammatory activation in subjects with acute coronary syndrome and left ventricular dysfunction. Inflammation 35:363\u2013370","journal-title":"Inflammation"},{"issue":"1","key":"5877_CR9","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s10238-006-0092-9","volume":"6","author":"AL Pasqui","year":"2006","unstructured":"Pasqui AL, Di Renzo M, Bova G, Maffei S, Pompella G, Auteri A, Puccetti L (2006) Pro-inflammatory\/anti-inflammatory cytokine imbalance in acute coronary syndromes. Clin Exp Med 6(1):38\u201344","journal-title":"Clin Exp Med"},{"key":"5877_CR10","first-page":"186","volume":"64","author":"M Seishima","year":"2016","unstructured":"Seishima M (2016) Physiological function of apolipoproteins and atherosclerosis. RinshoByori 64:186\u2013192","journal-title":"RinshoByori"},{"key":"5877_CR11","unstructured":"Hansson, (2010) Inflammatory. Atheroslerosis 1-35."},{"key":"5877_CR12","doi-asserted-by":"crossref","first-page":"4555","DOI":"10.1007\/s13277-015-3100-4","volume":"36","author":"YL Yifan Sun","year":"2015","unstructured":"Yifan Sun YL, Pen Q, Li T, Xie L, Deng Y et al (2015) Interferon gamma +874 T\/A polymorphism increases the risk of cervical cancer: evidence from a meta-analysis. Tumor Biol 36:4555\u20134564","journal-title":"Tumor Biol"},{"key":"5877_CR13","first-page":"0121168","volume":"4","author":"Y Sun","year":"2015","unstructured":"Sun Y, Lu Y, Li T, Xie L, Deng Y, Li S, Qin X (2015) Interferon gamma +874 T\/A polymorphism increases the risk of hepatit virus-related disease: evidence from a meta-analysis. Plos One 4:0121168","journal-title":"Plos One"},{"key":"5877_CR14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10528-017-9839-0","volume":"56","author":"E Teker","year":"2018","unstructured":"Teker E, Akadam-Teker AB, Ozturk O, Eronat AP, Yalin K, Golcuk SE, Bugra Z (2018) Association between the interferon gamma 874 T\/A polymorphism and the severity of valvular damage in patients with rheumatic heart disease. Biochem Genet 56:225\u2013234","journal-title":"Biochem Genet"},{"key":"5877_CR15","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.acvd.2016.04.002","volume":"109","author":"S Taleb","year":"2016","unstructured":"Taleb S (2016) Inflammation in atherosclerosis. Arch Cardiovas Dis 109:708\u2013715","journal-title":"Arch Cardiovas Dis"},{"key":"5877_CR16","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1073\/pnas.92.18.8264","volume":"92","author":"JD Smith","year":"1995","unstructured":"Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miy-ata M (1995) Decreased atherosclerosis in mice deficient in bothmacrophage colony-stimulating factor (op) and apolipoproteinE. ProcNatlAcadSci USA 92:8264\u20138288","journal-title":"ProcNatlAcadSci USA"},{"key":"5877_CR17","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1073\/pnas.94.9.4642","volume":"94","author":"HM Dansky","year":"1997","unstructured":"Dansky HM, Charlton SA, Harper MM, Smith JD (1997) T and B lym-phocytes play a minor role in atherosclerotic plaque formationin the apolipoprotein E-deficient mouse. ProcNatlAcadSci USA 94:4642\u20134646","journal-title":"ProcNatlAcadSci USA"},{"key":"5877_CR18","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI119681","volume":"100","author":"A Daugherty","year":"1997","unstructured":"Daugherty A, Pure E, Delfel-Butteiger D et al (1997) The effects oftotal lymphocyte deficiency on the extent of atherosclerosis inapolipoprotein E\u2014\/\u2014 mice. J Clin Invest. 100:1575\u20131580","journal-title":"J Clin Invest."},{"key":"5877_CR19","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0198-8859(00)00167-1","volume":"61","author":"V Pravica","year":"2000","unstructured":"Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV (2000) A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 61:863\u2013866","journal-title":"Hum Immunol"},{"key":"5877_CR20","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 310:2191\u20132194","journal-title":"JAMA"},{"key":"5877_CR21","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.2174\/138161212802481237","volume":"18","author":"A Tuttolomondo","year":"2012","unstructured":"Tuttolomondo A, D\u0131 Ra\u0131mondo D, Pecoraro R, Arnao V, P\u0131nto A, L\u0131cata G (2012) Atherosclerosis as an inflammatory disease. Curr Pharm Des 18:4266\u20134288","journal-title":"Curr Pharm Des"},{"key":"5877_CR22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-0037-1619816","volume":"35","author":"C Weber","year":"2015","unstructured":"Weber C, Hr\u0131stov M (2015) Atherogenesis and inflammation. From cellular mediators to regulatory mechanisms of inflammation in atherosclerosis. Hamostaseologie 35:99\u2013101","journal-title":"Hamostaseologie"},{"key":"5877_CR23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrd3444","volume":"10","author":"IF Charo","year":"2011","unstructured":"Charo IF, Taub R (2011) Anti-inflammatory therapeutics for the treatment of atherosclerosis. Nat Rev Drug Discov 10:365\u2013376","journal-title":"Nat Rev Drug Discov"},{"key":"5877_CR24","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nature10146","volume":"473","author":"P L\u0131bby","year":"2011","unstructured":"L\u0131bby P, R\u0131dker PM, Hansson GK (2011) Progress and challenges in translating the biology of atherosclerosis. Nature. 473:317\u2013325","journal-title":"Nature."},{"key":"5877_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0021-9150(99)00011-8","volume":"145","author":"J Frosteg\u00e5rd","year":"1999","unstructured":"Frosteg\u00e5rd J, Ulfgren AK, Nyberg P, Hedin U, Swedenborg J, Andersson U, Hansson GK (1999) Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines. Atherosclerosis 145:33\u201343","journal-title":"Atherosclerosis"},{"issue":"11","key":"5877_CR26","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","volume":"99","author":"S Gupta","year":"1997","unstructured":"Gupta S, Pablo AM, Jiang XC, Wang N, Tall AR, Schindler C (1997) IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 99(11):2752\u20132761","journal-title":"J Clin Invest"},{"key":"5877_CR27","first-page":"454","volume":"23","author":"C Buono","year":"2003","unstructured":"Buono C, Come CE, Stavrakis G, Maguire GF, Connelly PW, Lichtman AH (2003) Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. ArteriosclerThrombVascBiol 23:454\u201360","journal-title":"ArteriosclerThrombVascBiol"},{"key":"5877_CR28","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1172\/JCI1216","volume":"101","author":"XH Zhou","year":"1998","unstructured":"Zhou XH, Paulsson G, Stemme S, Hansson GK (1998) Hypercholesterolemia is associated with a T helper (Th) 1\/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 101:1717\u20131725","journal-title":"J Clin Invest"},{"key":"5877_CR29","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","volume":"6","author":"GK Hansson","year":"2006","unstructured":"Hansson GK, Libby P (2006) The immune response in atherosclerosis: a doubleedged sword. Nat Rev Immunol 6:508\u2013519","journal-title":"Nat Rev Immunol"},{"key":"5877_CR30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/nm1567","volume":"13","author":"J Bernhagen","year":"2007","unstructured":"Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR et al (2007) MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med 13:587\u2013596","journal-title":"Nat Med"},{"key":"5877_CR31","first-page":"467","volume":"42","author":"H Mangge","year":"2004","unstructured":"Mangge H, Hubmann H, Pilz S, Schauenstein K, Renner W, Marz W (2004) Beyond cholesterol\u2013inflammatory cytokines, the key mediators in atherosclerosis. ClinChem Lab Med 42:467\u2013474","journal-title":"ClinChem Lab Med"},{"key":"5877_CR32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cardiores.2005.04.019","volume":"67","author":"EJ Harvey","year":"2005","unstructured":"Harvey EJ, Ramji DP (2005) Interferon-and atherosclerosis: pro- or antiatherogenic? Cardiovasc Res 67:11\u201320","journal-title":"Cardiovasc Res"},{"key":"5877_CR33","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","volume":"157","author":"SC Whitman","year":"2000","unstructured":"Whitman SC, Ravisankar P, Elam H, Daugherty A (2000) Exogenous interferon-\u03b3 enhances atherosclerosis in apolipoprotein E\u2212\/\u2212 Mice. Am J Pathol 157:1819\u20131824","journal-title":"Am J Pathol"},{"key":"5877_CR34","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCRESAHA.106.147256","volume":"101","author":"M Koga","year":"2007","unstructured":"Koga M, Kai H, Yasukawa H, Yamamoto T, Kawai Y, Kato S, Kusaba K, Kai M, Egashira K, Kataoka Y, Imaizumi T (2007) Inhibition of progression and stabilization of plaques by postnatal interferon-gamma function blocking in ApoE-knockout mice. Circ Res 101:348\u2013356","journal-title":"Circ Res"},{"key":"5877_CR35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1291\/hypres.30.259","volume":"30","author":"M Koga","year":"2007","unstructured":"Koga M, Kai H, Yasukawa H, Kato S, Yamamoto T, Kawai Y, Kusaba K, Seki Y, Kai M, Egashira K, Kataoka Y, Imaizumi T (2007) Postnatal blocking of interferon-gamma function prevented atherosclerotic plaque formation in apolipoprotein E-knockout mice. Hypertens Res 30:259\u2013267","journal-title":"Hypertens Res"},{"key":"5877_CR36","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/15257770.2018.1489964","volume":"38","author":"S Tabaei","year":"2019","unstructured":"Tabaei S, Mehrad-Majd H, Soori M, Tabaee S (2019) The effect of tumor necrosis factor alpha (-308G\/a) and interferon gamma (+874T\/a) polymorphisms on susceptibility to coronary heart disease. Nucleosides Nucleotides Nucleic Acids. 38:701\u2013712","journal-title":"Nucleosides Nucleotides Nucleic Acids."},{"key":"5877_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.gene.2012.10.011","volume":"514","author":"PR Garg","year":"2013","unstructured":"Garg PR, Saraswathy KN, Kalla AK, Sinha E, Ghosh PK (2013) Pro-inflammatory cytokine gene polymorphisms and threat for coronary heart disease in a North Indian Agrawal population. Gene 514:69\u201374","journal-title":"Gene"},{"key":"5877_CR38","first-page":"614","volume":"53","author":"B Gyorffy","year":"2004","unstructured":"Gyorffy B, Kocsis I, Vasarhelyi B (2004) Biallelic genotype distributions in papers published in Gut between1998 and 2003: altered conclusions after recalculating the Hardy-Weinberg equilibrium. Gut 53:614\u2013616","journal-title":"Gut"},{"key":"5877_CR39","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/hmg\/ddg009","volume":"12","author":"C Levecque","year":"2003","unstructured":"Levecque C, Elbaz A, Clavel J, Richard F, Vidal JS, Amouyel P, Tzourio C, Alperovitch A, Chartier-Harlin MC (2003) Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet. 12:79\u201386","journal-title":"Hum Mol Genet."},{"issue":"5","key":"5877_CR40","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.0022-202X.2005.23709.x","volume":"124","author":"C Esser","year":"2005","unstructured":"Esser C, Tomluk J (2005) Reporting hardy-weinberg tests in case-control studies: reasons for caution but not for panic reactions. J Invest Dermatol 124(5):1082\u20131083","journal-title":"J Invest Dermatol"},{"key":"5877_CR41","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.gene.2017.07.050","volume":"628","author":"S Mastana","year":"2017","unstructured":"Mastana S, Prakash S, Akam EC, Kirby M, Lindley MR, Sinha N, Agrawal S (2017) Genetic association of pro-inflammatory cytokine gene polymorphisms with coronary artery disease (CAD) in a North Indian population. Gene 628:301\u2013307","journal-title":"Gene"},{"key":"5877_CR42","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0002-8703(95)90003-9","volume":"129","author":"T Mori","year":"1995","unstructured":"Mori T, Sasaki J, Kawaguchi H, Handa K, Takada Y, Matsunaga A, Kono S, Arakawa K (1995) Serum glycoproteins and severity of coronary atherosclerosis. Am Heart J 129:234\u2013238","journal-title":"Am Heart J"},{"key":"5877_CR43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/01.CIR.100.8.793","volume":"100","author":"I Ikonomidis","year":"1999","unstructured":"Ikonomidis I, Andreotti F, Economou E, Stefanadis C, Toutouzas P, Nihoyannopoulos P (1999) Increased proinflammatory cytokines in patients with chronic stable angina and their reduction by aspirin. Circulation 100:793\u2013798","journal-title":"Circulation"},{"issue":"19","key":"5877_CR44","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1053\/euhj.1999.2207","volume":"21","author":"A Woods","year":"2000","unstructured":"Woods A, Brull DJ, Humphries SE, Montgomery HE (2000) Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J 21(19):1574\u20131583","journal-title":"Eur Heart J"},{"key":"5877_CR45","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1524-6175.2006.05384.x","volume":"8","author":"R Dumaine","year":"2006","unstructured":"Dumaine R, Gibson CM, Murphy SA, Southard M, Ly HQ, McCabe CH, Giugliano RP, Cannon CP, Antman EM, Braunwald E (2006) Thrombolysis in myocardial infarction (TIMI) study group. Association of a history of systemic hypertension with mortality, thrombotic, and bleeding complications following non-ST-segment elevation acute coronary syndrome. J ClinHypertens (Greenwich) 8:315\u2013322","journal-title":"J ClinHypertens (Greenwich)"},{"key":"5877_CR46","doi-asserted-by":"publisher","first-page":"653903","DOI":"10.4061\/2011\/653903","volume":"2011","author":"O Olafiranye","year":"2011","unstructured":"Olafiranye O, Zizi F, Brimah P, Jean-Louis G, Makaryus AN, McFarlane S, Ogedegbe G (2011) Management of hypertension among patients with coronary heart disease. Int J Hypertens 2011:653903. https:\/\/doi.org\/10.4061\/2011\/653903","journal-title":"Int J Hypertens"},{"key":"5877_CR47","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr, Williamson JD, Wright JT Jr (2018) ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the american college of cardiology\/american heart association task force on clinical practice guidelines. Hypertension 71:1269\u20131324","journal-title":"Hypertension"},{"key":"5877_CR48","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","volume":"383","author":"E Rapsomaniki","year":"2014","unstructured":"Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, Shah AD, Denaxas S, White IR, Caulfield MJ, Deanfield JE, Smeeth L, Williams B, Hingorani A, Hemingway H (2014) Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 383:1899\u20131911","journal-title":"Lancet"},{"issue":"9438","key":"5877_CR49","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, McQueen M, Budaj A, Pais P, Varigos J, Lisheng L (2004) Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 364(9438):937\u2013952","journal-title":"Lancet"},{"issue":"1","key":"5877_CR50","first-page":"27","volume":"13","author":"P Wang","year":"2020","unstructured":"Wang P, Yao J, Xie Y, Luo M (2020) Gender-specific predictive markers of poor prognosis for patients with acute myocardial infarction during a 6-month follow-up. J CardiovascTransl Res 13(1):27\u201338","journal-title":"J CardiovascTransl Res"},{"key":"5877_CR51","first-page":"97","volume":"13","author":"X Wu","year":"2020","unstructured":"Wu X, Chen M, Wang K, Gao R, Li X (2020) Gender differences in prognostic markers of all-cause death in patients with acute heart failure: a prospective 18-month follow-up study. J CardiovascTransl Res 13:97\u2013109","journal-title":"J CardiovascTransl Res"},{"key":"5877_CR52","first-page":"3","volume":"13","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Liu B, Zhao R, Zhang S, Yu XY, Li Y (2020) The influence of sex on cardiac physiology and cardiovascular diseases. J CardiovascTransl Res 13:3\u201313","journal-title":"J CardiovascTransl Res"},{"key":"5877_CR53","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/eurheartj\/ehn018","volume":"29","author":"SS Anand","year":"2008","unstructured":"Anand SS, Islam S, Rosengren A, Franzosi MG, Steyn K, Yusufali AH, Keltai M, Diaz R, Rangarajan S, Yusuf S (2008) Risk factors for myocardial infarction in women and men: insights from the INTERHEART study. Eur Heart J 29:932\u2013940","journal-title":"Eur Heart J"},{"key":"5877_CR54","first-page":"846","volume":"27","author":"HY Wen","year":"2011","unstructured":"Wen HY, Peng YD, Cheng LX (2011) Study on the correlation of the levels of serum IFN-\u03b3 and RANTES and rabbit vulnerable atherosclerotic plaque. Xi Bao Yu Fen ZiMian Yi XueZaZhi 27:846\u2013848","journal-title":"Xi Bao Yu Fen ZiMian Yi XueZaZhi"},{"key":"5877_CR55","first-page":"12883","volume":"10","author":"G Liuzzo","year":"2000","unstructured":"Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, Weyand CM (2000) Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation 10:12883\u20132888","journal-title":"Circulation"},{"key":"5877_CR56","first-page":"6034","volume":"25","author":"C Li","year":"2019","unstructured":"Li C, Zong W, Zhang M, Tu Y, Zhou Q, Ni M, Li Z, Liu H, Zhang J (2019) Increased ratio of circulating T-Helper 1 to T-Helper 2 cells and severity of coronary artery disease in patients with acute myocardial infarction: a prospective observational study. Med SciMonit 25:6034\u20136042","journal-title":"Med SciMonit"},{"key":"5877_CR57","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5493\/wjem.v5.i3.154","volume":"5","author":"JW Moss","year":"2015","unstructured":"Moss JW, Ramji DP (2015) Interferon-\u03b3: promising therapeutic target in atherosclerosis. World J Exp Med 5:154\u2013159","journal-title":"World J Exp Med"},{"key":"5877_CR58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.tcm.2013.06.003","volume":"24","author":"I Voloshyna","year":"2014","unstructured":"Voloshyna I, Littlefield MJ, Reiss AB (2014) Atherosclerosis and interferon-\u03b3: new insights and therapeutic targets. Trends Cardiovasc Med 24:45\u201351","journal-title":"Trends Cardiovasc Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-020-05877-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-020-05877-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,26]],"date-time":"2021-10-26T01:30:59Z","timestamp":1635211859000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-020-05877-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,26]]},"references-count":58,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["5877"],"URL":"https:\/\/doi.org\/10.1007\/s11033-020-05877-7","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"type":"print","value":"0301-4851"},{"type":"electronic","value":"1573-4978"}],"subject":[],"published":{"date-parts":[[2020,10,26]]},"assertion":[{"value":"4 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Authors declare that no conflict of interests exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the Declaration of Helsinki (2013). Ethical approval for this study was obtained from Giresun University Local Ethical Committee (KAEK-83).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"An informed consent form was obtained from the subjects before the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}